Filing Details
- Accession Number:
- 0001567619-23-000069
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-03 20:30:25
- Reporting Period:
- 2022-12-29
- Accepted Time:
- 2023-01-03 20:30:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1305253 | Eiger Biopharmaceuticals Inc. | EIGR | Biological Products, (No Disgnostic Substances) (2836) | 361004130 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1600361 | Christine Murray | C/O Eiger Biopharmaceuticals, Inc. 2155 Park Blvd. Palo Alto CA 94306 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-12-29 | 5,000 | $1.22 | 11,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
